key: cord-0013731-yid2rv8a
authors: Li, Jin-yi; Huang, Wei-qiang; Tu, Rong-hui; Zhong, Guo-qiang; Luo, Bei-bei; He, Yan
title: Retraction Note: Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt
date: 2020-01-17
journal: Acta Pharmacol Sin
DOI: 10.1038/s41401-020-0363-0
sha: 0e090a37be6047d9bbaace707ba93dee47572bf4
doc_id: 13731
cord_uid: yid2rv8a

nan

The Editor has retracted this article [1] because there is significant overlap of figures and text with [2] .

Specifically:

• Figure 1a [1] appears to be identical with sub panels in Figs. 1b and 1d [2] • Figure 1d [1] appears to be identical with a sub-panel in Fig. 1e Figure 3a [1] appears to be identical with Fig. 3b [2]

• Figure 3b [1] appears to be identical with Fig. 3c [2]

• Figures 5a, 5c, 5d and 5f in [1] appear to be identical with Figs. 6a, 6b, 6c and 6d in [2] , respectively • Figure 6b [1] appears to be identical with Fig. 8a [2]

The Editor therefore has no confidence in this article.

Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt

Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasome-PTEN-Akt-eNOS pathway

The authors have told us that all the Western blots in this article were produced by an external experimental company; this was not stated in the article. [All authors agree with this retraction.]